| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 06/20/2002 | WO2002030888A3 Tricyclic compounds and uses thereof |
| 06/20/2002 | WO2002016312A3 NOVEL COMPOUNDS INHIBITING FACTOR Xa ACTIVITY |
| 06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 06/20/2002 | WO2002004422A3 Heterocycle carboxamides as antiviral agents |
| 06/20/2002 | US20020077481 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates |
| 06/20/2002 | US20020077480 Methods for synthesis of amino-tetrahydroisoquinoline ring compounds |
| 06/20/2002 | US20020077357 For therapy of autoimmune disease |
| 06/20/2002 | US20020077338 HIV protease inhibitors |
| 06/20/2002 | US20020077336 (7-(3-Carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 06/20/2002 | US20020077333 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (TNF-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (COX-2) |
| 06/20/2002 | US20020076648 Optical data medium containing, in the information layer, a phthalocyanine dye as a light-absorbing compound |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/18/2002 | US6407285 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors |
| 06/13/2002 | WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046164A1 Therapeutic compounds |
| 06/13/2002 | WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
| 06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/12/2002 | EP1213280A2 A process for the preparation of amine oxides |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/11/2002 | US6403799 Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403608 3-Substituted isoquinolin-1-yl derivatives |
| 06/11/2002 | US6403607 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | CA2262692C Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 06/11/2002 | CA2198578C Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/06/2002 | WO2002044166A1 Substituted quinolines as antitumor agents |
| 06/06/2002 | US20020068734 Nitrogen-containing heterocyclic compounds |
| 06/05/2002 | EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS |
| 06/05/2002 | EP1210598A1 4-unsubstituted dihydroisoquinolinone derivatives and combinatorial libraries thereof |
| 06/05/2002 | EP1210330A1 Antibacterial agents |
| 06/05/2002 | EP0923539B1 Compounds with growth hormone releasing properties |
| 06/05/2002 | CN1352632A N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor |
| 06/04/2002 | US6399808 Reacting amine with carbon dioxide in anhydrous solvent |
| 06/04/2002 | US6399774 Compounds having activity as inhibitors of cytochrome P450RAI |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |
| 06/04/2002 | US6399223 Compound for use in organic EL device and organic EL device |
| 06/04/2002 | CA2067929C Piperazine derivatives |
| 06/04/2002 | CA2060557C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 05/30/2002 | WO2002042277A1 Novel compounds for use as hiv protease inhibitors |
| 05/30/2002 | WO2002042276A1 Quarternary proforms of tertiary amine containing compounds |
| 05/30/2002 | WO2002042265A2 Cyanoguanidine prodrugs |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | US20020065326 Patient oxygenation using stabilized fluorocarbon emulsions |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | CA2428459A1 Novel compounds for use as hiv protease inhibitors |
| 05/30/2002 | CA2426601A1 Cyanoguanidine prodrugs |
| 05/29/2002 | EP1209148A1 Process for the preparation of amine oxides |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP1208087A2 Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid |
| 05/28/2002 | US6395749 Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
| 05/28/2002 | CA2203618C New metalloprotease inhibitors, their preparation process and the pharmaceutical compounds that contain them |
| 05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | WO2002040449A1 Dihydroisoquinolines as novel phosphodiesterase inhibitors |
| 05/23/2002 | US20020061885 Treatment of tumor growth, metastasis, restenosis, osteoporosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, sickle cell anemia, nerve system disorders |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP0923510B1 Method for nitration of aromatic compounds |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/21/2002 | US6392067 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
| 05/21/2002 | US6391877 Eating disorders; sexual disorders; antidepressants; antiepileptic agents |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002002090A3 Inhibitors of copper-containing amine oxidases |
| 05/16/2002 | WO2001092228A3 Process for the synthesis of amine ethers from secondary amino oxides |
| 05/16/2002 | US20020058815 Methods for synthesis of amino-tertahydroisoquinoline-sulfonamide hydroxamic acids |
| 05/16/2002 | US20020058677 Isoquinolone inhibitors of factor Xa |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
| 05/15/2002 | CN1084736C Substituted bheterocyclic carboxamide esters, their prepn. and their use as pharmaceuticals |
| 05/15/2002 | CN1084619C Process for preparing medicine composition |
| 05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 05/14/2002 | US6388078 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387547 Compound having naphthacene skeleton for use in organic electroluminescence device; produces light emission of satisfactory luminance, especially at long wavelength; improved light emitting performance lasts for long time |
| 05/10/2002 | WO2002036571A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | CA2427613A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/09/2002 | US20020055637 Methods for synthesis of amino-tetrahydroisoquinoline-carboxylic acids |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP0914332B1 Isoquinolines useful as analgesics |
| 05/08/2002 | CN1348444A 丝氨酸蛋白酶抑制剂 Serine protease inhibitors |
| 05/07/2002 | US6384028 Treatment of cardiovascular disorders, anticoagulants and valve replacement |
| 05/02/2002 | WO2002034760A2 Compounds and methods |
| 05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 05/02/2002 | WO2001085675A3 Fluorous tagging compounds and their use |
| 05/02/2002 | WO2001064642A3 Benzamides and related inhibitors of factor xa |